814 related articles for article (PubMed ID: 29080699)
1. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
Schunck WH; Konkel A; Fischer R; Weylandt KH
Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
[TBL] [Abstract][Full Text] [Related]
2. CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?
Westphal C; Konkel A; Schunck WH
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):99-108. PubMed ID: 21945326
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450-derived eicosanoids and heart function.
Jamieson KL; Endo T; Darwesh AM; Samokhvalov V; Seubert JM
Pharmacol Ther; 2017 Nov; 179():47-83. PubMed ID: 28551025
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.
Arnold C; Konkel A; Fischer R; Schunck WH
Pharmacol Rep; 2010; 62(3):536-47. PubMed ID: 20631419
[TBL] [Abstract][Full Text] [Related]
5. Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids.
Arnold C; Markovic M; Blossey K; Wallukat G; Fischer R; Dechend R; Konkel A; von Schacky C; Luft FC; Muller DN; Rothe M; Schunck WH
J Biol Chem; 2010 Oct; 285(43):32720-32733. PubMed ID: 20732876
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory ω-3 endocannabinoid epoxides.
McDougle DR; Watson JE; Abdeen AA; Adili R; Caputo MP; Krapf JE; Johnson RW; Kilian KA; Holinstat M; Das A
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6034-E6043. PubMed ID: 28687674
[TBL] [Abstract][Full Text] [Related]
7. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.
Kalkman HO; Hersberger M; Walitza S; Berger GE
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922396
[TBL] [Abstract][Full Text] [Related]
8. Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.
Fischer R; Konkel A; Mehling H; Blossey K; Gapelyuk A; Wessel N; von Schacky C; Dechend R; Muller DN; Rothe M; Luft FC; Weylandt K; Schunck WH
J Lipid Res; 2014 Jun; 55(6):1150-64. PubMed ID: 24634501
[TBL] [Abstract][Full Text] [Related]
9. [Essential fatty acids and lipid mediators. Endocannabinoids].
Caramia G
Pediatr Med Chir; 2012; 34(2):65-72. PubMed ID: 22730630
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective mechanisms of cytochrome P450 derived oxylipins from ω-3 and ω-6 PUFAs.
Cho C; Aliwarga T; Wiley AM; Totah RA
Adv Pharmacol; 2023; 97():201-227. PubMed ID: 37236759
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytochrome P450-dependent epoxyeicosanoids on Ristocetin-induced thrombocyte aggregation.
Jung F; Schulz C; Blaschke F; Muller DN; Mrowietz C; Franke RP; Lendlein A; Schunck WH
Clin Hemorheol Microcirc; 2012; 52(2-4):403-16. PubMed ID: 22975950
[TBL] [Abstract][Full Text] [Related]
12. Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting.
Schmöcker C; Zhang IW; Kiesler S; Kassner U; Ostermann AI; Steinhagen-Thiessen E; Schebb NH; Weylandt KH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316682
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids and inflammatory processes: from molecules to man.
Calder PC
Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome p450 enzymes in the bioactivation of polyunsaturated Fatty acids and their role in cardiovascular disease.
Westphal C; Konkel A; Schunck WH
Adv Exp Med Biol; 2015; 851():151-87. PubMed ID: 26002735
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization.
Yanai R; Mulki L; Hasegawa E; Takeuchi K; Sweigard H; Suzuki J; Gaissert P; Vavvas DG; Sonoda KH; Rothe M; Schunck WH; Miller JW; Connor KM
Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9603-8. PubMed ID: 24979774
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of Endotoxemia by a Synthetic Analog of Omega-3 Epoxyeicosanoids.
Shikuma A; Kami D; Maeda R; Suzuki Y; Sano A; Taya T; Ogata T; Konkel A; Matoba S; Schunck WH; Gojo S
Front Immunol; 2022; 13():825171. PubMed ID: 35281027
[TBL] [Abstract][Full Text] [Related]
17. Significance of long chain polyunsaturated fatty acids in human health.
Zárate R; El Jaber-Vazdekis N; Tejera N; Pérez JA; Rodríguez C
Clin Transl Med; 2017 Dec; 6(1):25. PubMed ID: 28752333
[TBL] [Abstract][Full Text] [Related]
18. Possible Role of CYP450 Generated Omega-3/Omega-6 PUFA Metabolites in the Modulation of Blood Pressure and Vascular Function in Obese Children.
Bonafini S; Giontella A; Tagetti A; Marcon D; Montagnana M; Benati M; Gaudino R; Cavarzere P; Karber M; Rothe M; Minuz P; Antonazzi F; Maffeis C; Schunck WH; Fava C
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400671
[TBL] [Abstract][Full Text] [Related]
19. Impact of intravenous fish oil on omega-3 fatty acids and their derived lipid metabolites in patients with parenteral nutrition.
Weylandt KH; Karber M; Xiao Y; Zhang IW; Pevny S; Blüthner E; von Schacky C; Rothe M; Schunck WH; Pape UF
JPEN J Parenter Enteral Nutr; 2023 Feb; 47(2):287-300. PubMed ID: 36164258
[TBL] [Abstract][Full Text] [Related]
20. Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors.
Dawczynski C; Massey KA; Ness C; Kiehntopf M; Stepanow S; Platzer M; Grün M; Nicolaou A; Jahreis G
Clin Nutr; 2013 Oct; 32(5):686-96. PubMed ID: 23332800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
